October 2023 Press Releases Chimeric Therapeutics Announces FDA Clearance of IND Application for CHM 2101, A Novel CDH17 CAR T Cell Therapy for Advanced Gastrointestinal Cancers
PrevPreviousPositive Preliminary Phase 1A Data For CLTX CAR T in Recurrent Brain Cancer Clinical Trial